Skip to main content
Top
Published in: Acta Diabetologica 1/2012

01-12-2012 | Original Article

Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality

Authors: Lixin Guo, Yang Cheng, Xiaoxia Wang, Qi Pan, Hui Li, Lina Zhang, Yao Wang

Published in: Acta Diabetologica | Special Issue 1/2012

Login to get access

Abstract

The objective of this study is to investigate the correlation of urinary albumin excretion rate (UAER) with the incidence of coronary heart disease (CHD), pathological characteristics and severity of coronary atherosclerosis in patients with type 2 diabetes mellitus (T2DM), and explore the efficacy of using the urinary albumin excretion rate (UAER) to predict the risk of CHD in patients with T2DM. The study included 1,004 T2DM patients with normo- and micro-albuminuria who underwent coronary angiography for suspected coronary atherosclerosis. The severity of coronary atherosclerosis was defined using the Gensini’s score system. The correlation of UAER with the incidence of CHD, pathological characteristic and the severity of coronary atherosclerosis in patients with T2DM was analyzed. The best numerical value of UAER in predicting the risk of CHD in patients with T2DM was calculated. The differences in sex, age, BMI, SBP, history of smoking, duration of diabetes mellitus, HbA1C, FPG, LDL-C, HDL-C, Cre, Uric acid, HOMA-IR between microalbuminuria(MAU) subgroup and normal albuminuria subgroup were statistically significant(P < 0.05). The differences in the incidence of CHD, the number of pathological coronary vessels, the Gensini’s score and LVEF% between microalbuminuria group and normal albuminuria group were statistically significant (P < 0.05). UAER increased significantly with an increase in the number of pathological coronary vessels. Logistic multiple regression analysis showed that UAER was independently correlated with the incidence of CHD (OR = 1.092, P = 0.000, 95% CI = 1.063–1.122). Spearman’s correlation analysis showed that the Gensini’s score was significantly positively correlated with UAER, sex, age, BMI, SBP, the history of smoking and drinking, the duration of diabetes mellitus, HbA1c, FPG, PPG, LDL-C, Cre, C-reactive protein (CRP), uric acid (UA). Based on the ROC curve, the 11.275 μg/min of UAER was the best numerical value to predict the risk of CHD in patients with T2DM. Area under the curve was 0.799, sensitivity was 65.1%, and specificity was 82.9%. Conclusion: Microalbuminuria in patients with T2DM is another risk factor for CHD. Microalbuminuria is significantly positively correlated with the severity of coronary atherosclerosis. An UAER value of 11.275 μg/min can be used to predict the risk of CHD in patients with T2DM.
Literature
1.
go back to reference Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1(8287):1430–1432PubMedCrossRef Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1(8287):1430–1432PubMedCrossRef
2.
go back to reference Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE (1990) Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300(6720):297–300PubMedCrossRef Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE (1990) Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300(6720):297–300PubMedCrossRef
3.
go back to reference Dinneen F, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157:1413–1418PubMedCrossRef Dinneen F, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 157:1413–1418PubMedCrossRef
4.
go back to reference Jay PG, George LB (2002) Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 7:35–43CrossRef Jay PG, George LB (2002) Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 7:35–43CrossRef
5.
go back to reference Jinxia L, Tianchang L (2006) Value of microalbuminuria in predicting the risk of coronary heart disease. Chin J Med Chem 8(2):83–87 Jinxia L, Tianchang L (2006) Value of microalbuminuria in predicting the risk of coronary heart disease. Chin J Med Chem 8(2):83–87
6.
go back to reference Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110(1):32–35PubMedCrossRef Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110(1):32–35PubMedCrossRef
7.
go back to reference Tominaga M (1999) Diagnostic criteria for diabetes mellitus. Rinsho Byori 47(10):901–908 Tominaga M (1999) Diagnostic criteria for diabetes mellitus. Rinsho Byori 47(10):901–908
8.
go back to reference Mei M, Haoye Y (2007) Relationship between different coronary scoring systems for determining severity of coronary heart disease. Chin Circ J 22(5):340–342 Mei M, Haoye Y (2007) Relationship between different coronary scoring systems for determining severity of coronary heart disease. Chin Circ J 22(5):340–342
9.
go back to reference Wu AY, Kong NC, De Leon FA et al (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the Microalbuminuria Prevalence (MAP) study. Diabetologia 48(1):17–26PubMedCrossRef Wu AY, Kong NC, De Leon FA et al (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the Microalbuminuria Prevalence (MAP) study. Diabetologia 48(1):17–26PubMedCrossRef
10.
go back to reference Fowler PB (1998) The UK prospective diabetes study. Lancet 352(12):1933 Fowler PB (1998) The UK prospective diabetes study. Lancet 352(12):1933
11.
go back to reference Clausen P, Jensen JS, Jensen G et al (2001) Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103(14):1869–1874PubMedCrossRef Clausen P, Jensen JS, Jensen G et al (2001) Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103(14):1869–1874PubMedCrossRef
12.
go back to reference Hillege HL, Fidler V, Diercks GF et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14):1777–1782PubMedCrossRef Hillege HL, Fidler V, Diercks GF et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14):1777–1782PubMedCrossRef
13.
go back to reference Hua J, Jianguo W, Wosu Z (2000) The features of coronary angiography in coronary heart disease with type 2 diabetes mellitus. Chin J Intervent Cardiol 8(3):118–120 Hua J, Jianguo W, Wosu Z (2000) The features of coronary angiography in coronary heart disease with type 2 diabetes mellitus. Chin J Intervent Cardiol 8(3):118–120
14.
go back to reference Mojiminiyi OA, Abdella N, Moussa MA et al (2002) Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 58:37–44PubMedCrossRef Mojiminiyi OA, Abdella N, Moussa MA et al (2002) Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 58:37–44PubMedCrossRef
15.
go back to reference Jie W, Zhiqiang L (2005) A epidemiological cross-sectional survey of microalbuminuria and risk factors in type 2 diabetic patients. Clin Med J Chin 12(5):859–861 Jie W, Zhiqiang L (2005) A epidemiological cross-sectional survey of microalbuminuria and risk factors in type 2 diabetic patients. Clin Med J Chin 12(5):859–861
16.
go back to reference Makino H, Doi K et al (2008) Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes Res Clin Pract 79:177–182PubMedCrossRef Makino H, Doi K et al (2008) Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes Res Clin Pract 79:177–182PubMedCrossRef
17.
go back to reference Jayasinghe SR, Jayasinghe SH (2009) Variant metabolic risk factor profile leading to premature coronary disease: time to define the syndrome of accelerated atherocoronary metabolic syndrome in Asian Indians. Singapore Med J 50(10):949–955PubMed Jayasinghe SR, Jayasinghe SH (2009) Variant metabolic risk factor profile leading to premature coronary disease: time to define the syndrome of accelerated atherocoronary metabolic syndrome in Asian Indians. Singapore Med J 50(10):949–955PubMed
18.
go back to reference Cosson E, Pham I, Valensi P et al (2006) Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care 29(1):107–112PubMedCrossRef Cosson E, Pham I, Valensi P et al (2006) Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care 29(1):107–112PubMedCrossRef
19.
go back to reference Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906PubMedCrossRef Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906PubMedCrossRef
20.
go back to reference Ping L, Yu L, Jianjun Y (2004) Relationship between microalbuminuria and endothelium-dependent vasodilation in type 2 diabetes mellitus. Chin J Misdiagnostic 4(10):1640–1641 Ping L, Yu L, Jianjun Y (2004) Relationship between microalbuminuria and endothelium-dependent vasodilation in type 2 diabetes mellitus. Chin J Misdiagnostic 4(10):1640–1641
21.
go back to reference Yibin Y, Zhongxia C, Kun X (2005) Measurements of the marker for endothelial damages and their links with urinary protein in patients with diabetes mellitus. J Postgrad Med 28(5):21–23 Yibin Y, Zhongxia C, Kun X (2005) Measurements of the marker for endothelial damages and their links with urinary protein in patients with diabetes mellitus. J Postgrad Med 28(5):21–23
Metadata
Title
Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality
Authors
Lixin Guo
Yang Cheng
Xiaoxia Wang
Qi Pan
Hui Li
Lina Zhang
Yao Wang
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0205-5

Other articles of this Special Issue 1/2012

Acta Diabetologica 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.